Skip to content

Clinical trials

Terminated Hypertension, Pulmonary trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Terminated Country / region: Canada Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20093
20103
20121
20131
20141
20161
20172
20192
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion2
Biogen2
Gilead Sciences2
Novartis Pharmaceuticals2
University of Alberta2
Altavant Sciences GmbH1
Bayer1
Bellerophon Pulse Technologies1
Carelon Research1
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary22
Pulmonary Arterial Hypertension8
Lung Diseases, Interstitial3
Pulmonary Disease, Chronic Obstructive3
Cystic Fibrosis2
Heart Failure2
Pulmonary Fibrosis2
Asbestosis1
Asthma1
Bronchiectasis1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.